Variant report
Variant | nsv981340 |
---|---|
Chromosome Location | chr6:120909063-120917558 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs145123548 | chr6:120909138-120909139 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs557128088 | chr6:120909141-120909142 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs558458001 | chr6:120909163-120909164 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs570811688 | chr6:120909187-120909188 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs535602029 | chr6:120909293-120909294 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs553031569 | chr6:120909310-120909311 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs539703741 | chr6:120909339-120909340 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs575881204 | chr6:120909382-120909383 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs147598252 | chr6:120909410-120909411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs541834127 | chr6:120909416-120909417 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs555862188 | chr6:120909443-120909444 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs574861477 | chr6:120909456-120909457 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs191345957 | chr6:120909474-120909475 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs74462776 | chr6:120909507-120909508 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs370343209 | chr6:120909544-120909545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs140446771 | chr6:120909555-120909556 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs377118904 | chr6:120909558-120909559 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs201485650 | chr6:120909573-120909574 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs532465751 | chr6:120909600-120909601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs546053146 | chr6:120909654-120909655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs566297825 | chr6:120909666-120909667 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs1203068 | chr6:120909711-120909712 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs79199515 | chr6:120909753-120909754 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs558449316 | chr6:120909755-120909756 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs183305880 | chr6:120909765-120909766 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs187794573 | chr6:120909772-120909773 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs1767497 | chr6:120909823-120909824 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs9385168 | chr6:120909880-120909881 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs570676581 | chr6:120909881-120909882 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs539766517 | chr6:120909885-120909886 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs534530179 | chr6:120909892-120909893 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs73533887 | chr6:120909908-120909909 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs567035186 | chr6:120909914-120909915 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs80058614 | chr6:120909920-120909921 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs12204216 | chr6:120909925-120909926 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs555472272 | chr6:120909985-120909986 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs377326529 | chr6:120910032-120910033 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs541506760 | chr6:120910052-120910053 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs574465146 | chr6:120910074-120910075 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs142516846 | chr6:120910105-120910106 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs577139900 | chr6:120910131-120910132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs373799895 | chr6:120910169-120910170 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs535243627 | chr6:120910177-120910178 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs144352123 | chr6:120910237-120910238 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs1203067 | chr6:120910242-120910243 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs559640934 | chr6:120910276-120910277 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs528373070 | chr6:120910307-120910308 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs142592111 | chr6:120910328-120910329 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs10550053 | chr6:120910331-120910332 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs541810853 | chr6:120910343-120910344 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Ovarian cancer | 21720365 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 21364760 | CNVD |
Chordoma | 21602918 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17133270 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Mental retardation | 17621639 | CNVD |
Hypoplastic | 20877625 | CNVD |
Hypotonia | 20877625 | CNVD |
Mental retardation | 20877625 | CNVD |
Microcephaly | 20877625 | CNVD |
brachycephaly | 20877625 | CNVD |
epicanthic folds | 20877625 | CNVD |
micrognathia | 20877625 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Breast cancer | 18698023 | CNVD |
Mental retardation | 18854857 | CNVD |
Leukemia | 18688285 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Breast cancer | 21611746 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:120905600-120909800 | Enhancers | Brain Germinal Matrix | brain |
2 | chr6:120909000-120910000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
3 | chr6:120909800-120912000 | Weak transcription | Brain Germinal Matrix | brain |
4 | chr6:120910000-120915400 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
5 | chr6:120911000-120912600 | Enhancers | Fetal Brain Female | brain |
6 | chr6:120911400-120911600 | Enhancers | Fetal Brain Male | brain |
7 | chr6:120911600-120912400 | Weak transcription | Fetal Brain Male | brain |
8 | chr6:120912000-120913200 | Enhancers | Brain Germinal Matrix | brain |
9 | chr6:120912400-120913600 | Enhancers | Fetal Brain Male | brain |
10 | chr6:120912600-120915200 | Weak transcription | Fetal Brain Female | brain |
11 | chr6:120913200-120914200 | Weak transcription | Brain Germinal Matrix | brain |
12 | chr6:120914200-120914400 | Enhancers | Brain Germinal Matrix | brain |
13 | chr6:120915200-120915400 | Enhancers | Fetal Brain Female | brain |
14 | chr6:120915400-120917400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
15 | chr6:120916200-120916600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |